MedTrace Logo

Protective Analgesia for Postoperative Pain Relief Following Day Case Oral Surgery

NCT00895843 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2009-06-01

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to investigate whether robust analgesic regime (protective analgesia) can improve postoperative pain experience for patients undergoing lower wisdom teeth extraction under day case general anaesthetic.

Conditions

  • Postoperative Pain
  • Wisdom Tooth

Interventions

DRUG

Brufen retard

Single dose 2 x 800mg tablets 2 hours prior to surgery

DRUG

ibuprofen

Single dose ibuprofen 2 x 200mg tablets 2 hours prior to surgery

DRUG

Bupivacaine

Up to 10ml of Bupivacaine 0.5% with 1:200,000 Adrenaline given prior to surgical incision as inferior alveolar nerve block and long buccal nerve infiltration.

Sponsors & Collaborators

  • Manchester University NHS Foundation Trust

    collaborator OTHER_GOV

  • University of Manchester

    lead OTHER

Principal Investigators

  • Paul Coulthard, BDS FDS PhD · University of Manchester

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2007-12-31
Completion
2008-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00895843 on ClinicalTrials.gov